Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-07

Clinical Trial Update: PRM-151 in the Prevention of Scarring Following Trabeculectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PRM-151 to prevent scarring after trabeculectomy in glaucoma; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRM-151 (recombinant human pentraxin-2)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-07